Covered recipient · General Payments record

CHRISTINA FRIEDLY

Allopathic & Osteopathic Physicians Family Medicine

NPI: 1366920373
CMS profile: 8917100
Location: LAKESIDE PARK, KY

General Payments · PY2021–2024

$2,320.58

Reported across 125 records
CMS publication 2026-01-23

Latest program year · PY2024

$1,059.43

54 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Food and Beverage	$1,059.43	54

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
Astellas Pharma US Inc	$133.58	6
ABBVIE INC.	$106.86	5
Amgen Inc.	$85.69	4
Boehringer Ingelheim Pharmaceuticals, Inc.	$75.46	4
Lilly USA, LLC	$74.05	5
PFIZER INC.	$70.22	4
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$55.66	3
Phathom Pharmaceuticals, Inc.	$51.64	3
Edwards Lifesciences Corporation	$50.94	1
Antares Pharma, Inc.	$41.04	2
Exact Sciences Corporation	$40.43	2
Acerta Pharma LLC	$35.88	2
Novo Nordisk AS	$31.22	2
Esperion Therapeutics, Inc.	$30.07	2
Axsome Therapeutics, Inc.	$29.98	1
GlaxoSmithKline, LLC.	$28.29	2
Gilead Sciences, Inc.	$24.07	1
Merck Sharp & Dohme Corporation	$20.99	1
Teva Pharmaceuticals USA, Inc.	$20.09	1
Xeris Pharmaceuticals, Inc.	$20.02	1
Dynavax Technologies Corporation	$18.08	1
Neurocrine BioSciences, Inc.	$15.17	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2021	$52.15	3
PY2022	$321.99	19
PY2023	$887.01	49
PY2024	$1,059.43	54

Payment records · PY2024 (54)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2021 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
ABBVIE INC.	$17.34	01/12/2024	Food and Beverage	Undisputed	01/23/2026	1103755637	CMS
ABBVIE INC.	$20.15	01/23/2024	Food and Beverage	Undisputed	01/23/2026	1103755639	CMS
ABBVIE INC.	$19.71	03/23/2024	Food and Beverage	Undisputed	01/23/2026	1103755641	CMS
ABBVIE INC.	$14.68	06/13/2024	Food and Beverage	Undisputed	01/23/2026	1103755643	CMS
ABBVIE INC.	$34.98	07/30/2024	Food and Beverage	Undisputed	01/23/2026	1103755645	CMS
Amgen Inc.	$21.71	01/29/2024	Food and Beverage	Undisputed	01/23/2026	1117254967	CMS
Amgen Inc.	$14.57	04/15/2024	Food and Beverage	Undisputed	01/23/2026	1117254969	CMS
Amgen Inc.	$32.31	07/09/2024	Food and Beverage	Undisputed	01/23/2026	1111578265	CMS
Amgen Inc.	$17.10	09/04/2024	Food and Beverage	Undisputed	01/23/2026	1117254971	CMS
Antares Pharma, Inc.	$24.31	04/26/2024	Food and Beverage	Undisputed	01/23/2026	1146458926	CMS
Antares Pharma, Inc.	$16.73	07/29/2024	Food and Beverage	Undisputed	01/23/2026	1146458931	CMS
Astellas Pharma US Inc	$21.46	01/11/2024	Food and Beverage	Undisputed	01/23/2026	1139312214	CMS
Astellas Pharma US Inc	$25.17	03/19/2024	Food and Beverage	Undisputed	01/23/2026	1139272702	CMS
Astellas Pharma US Inc	$20.46	08/09/2024	Food and Beverage	Undisputed	01/23/2026	1139348500	CMS
Astellas Pharma US Inc	$21.25	08/19/2024	Food and Beverage	Undisputed	01/23/2026	1139334710	CMS
Astellas Pharma US Inc	$20.68	09/06/2024	Food and Beverage	Undisputed	01/23/2026	1139382822	CMS
Astellas Pharma US Inc	$24.56	12/13/2024	Food and Beverage	Undisputed	01/23/2026	1139441196	CMS
AstraZeneca Pharmaceuticals LP	$17.94	03/30/2024	Food and Beverage	Undisputed	01/23/2026	1104701295	CMS
AstraZeneca Pharmaceuticals LP	$17.94	04/08/2024	Food and Beverage	Undisputed	01/23/2026	1104313420	CMS
Axsome Therapeutics, Inc.	$29.98	02/19/2024	Food and Beverage	Undisputed	01/23/2026	1148271727	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$24.93	06/24/2024	Food and Beverage	Undisputed	01/23/2026	1117982996	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$17.34	08/13/2024	Food and Beverage	Undisputed	01/23/2026	1117982992	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$14.77	10/01/2024	Food and Beverage	Undisputed	01/23/2026	1117982990	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$18.42	12/02/2024	Food and Beverage	Undisputed	01/23/2026	1117982994	CMS
Dynavax Technologies Corporation	$18.08	07/17/2024	Food and Beverage	Undisputed	01/23/2026	1082149755	CMS
Edwards Lifesciences Corporation	$50.94	08/22/2024	Food and Beverage	Undisputed	01/23/2026	1138845645	CMS
Esperion Therapeutics, Inc.	$13.78	03/15/2024	Food and Beverage	Undisputed	01/23/2026	1129435230	CMS
Esperion Therapeutics, Inc.	$16.29	05/03/2024	Food and Beverage	Undisputed	01/23/2026	1129435232	CMS
Exact Sciences Corporation	$19.38	06/04/2024	Food and Beverage	Undisputed	01/23/2026	1114663868	CMS
Exact Sciences Corporation	$21.05	11/15/2024	Food and Beverage	Undisputed	01/23/2026	1114663874	CMS
Gilead Sciences, Inc.	$24.07	05/30/2024	Food and Beverage	Undisputed	01/23/2026	1133634349	CMS
GlaxoSmithKline, LLC.	$13.56	03/11/2024	Food and Beverage	Undisputed	01/23/2026	1115903760	CMS
GlaxoSmithKline, LLC.	$14.73	11/07/2024	Food and Beverage	Undisputed	01/23/2026	1116610088	CMS
Lilly USA, LLC	$13.97	01/22/2024	Food and Beverage	Undisputed	01/23/2026	1136097562	CMS
Lilly USA, LLC	$16.18	03/26/2024	Food and Beverage	Undisputed	01/23/2026	1136107687	CMS
Lilly USA, LLC	$14.51	06/26/2024	Food and Beverage	Undisputed	01/23/2026	1136094753	CMS
Lilly USA, LLC	$13.77	09/23/2024	Food and Beverage	Undisputed	01/23/2026	1136120560	CMS
Lilly USA, LLC	$15.62	10/14/2024	Food and Beverage	Undisputed	01/23/2026	1136107689	CMS
Merck Sharp & Dohme LLC	$20.99	07/10/2024	Food and Beverage	Undisputed	01/23/2026	1141961014	CMS
Neurocrine Biosciences, Inc.	$15.17	07/01/2024	Food and Beverage	Undisputed	01/23/2026	1150874682	CMS
Novo Nordisk Inc	$13.65	06/03/2024	Food and Beverage	Undisputed	01/23/2026	1097347510	CMS
Novo Nordisk Inc	$17.57	09/13/2024	Food and Beverage	Undisputed	01/23/2026	1096927126	CMS
PFIZER INC.	$20.04	01/10/2024	Food and Beverage	Undisputed	01/23/2026	1132007136	CMS
PFIZER INC.	$15.85	05/14/2024	Food and Beverage	Undisputed	01/23/2026	1132007138	CMS
PFIZER INC.	$16.64	06/05/2024	Food and Beverage	Undisputed	01/23/2026	1131605157	CMS
PFIZER INC.	$17.69	10/07/2024	Food and Beverage	Undisputed	01/23/2026	1132032619	CMS
Phathom Pharmaceuticals, Inc.	$15.05	02/16/2024	Food and Beverage	Undisputed	01/23/2026	1151063039	CMS
Phathom Pharmaceuticals, Inc.	$16.36	03/08/2024	Food and Beverage	Undisputed	01/23/2026	1151063041	CMS
Phathom Pharmaceuticals, Inc.	$20.23	03/08/2024	Food and Beverage	Undisputed	01/23/2026	1151063043	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$15.60	05/24/2024	Food and Beverage	Undisputed	01/23/2026	1153485079	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$19.62	07/11/2024	Food and Beverage	Undisputed	01/23/2026	1153566478	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$20.44	11/27/2024	Food and Beverage	Undisputed	01/23/2026	1153554207	CMS
Teva Pharmaceuticals USA, Inc.	$20.09	01/26/2024	Food and Beverage	Undisputed	01/23/2026	1151643645	CMS
Xeris Pharmaceuticals, Inc.	$20.02	10/08/2024	Food and Beverage	Undisputed	01/23/2026	1144590436	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2021, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.